English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Cheyenne Dickerson | May 14, 2017

Rosetta Genomics molecular test for thyroid patients receives final approval in New York

+ Technology/Innovation
Chandra Lye | May 11, 2017

Opdivo given European approval for patients with head and neck squamous cell cancer

+ Technology/Innovation
Robert Hadley | May 10, 2017

Health risk assessments may help identify early signs of depression

+ Technology/Innovation
Carol Ostrow | May 8, 2017

Stivarga wins approval to treat liver cancer

+ Technology/Innovation
Erianne Leatherman | May 7, 2017

Two $1.5 million grants to fund heart disease research

+ Technology/Innovation
Robert Hadley | May 7, 2017

$9 million grant to aid malaria research centers

+ Technology/Innovation
Ruth de Jauregui | May 7, 2017

Data from multiple sclerosis medication study shows promise

+ Technology/Innovation
Ruth de Jauregui | May 7, 2017

Sanfoli Genzyme releases 6 years of data on Lemtrada in patients with relapsing remitting multiple sclerosis

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily